Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
-
Bitcoin Bancorp Accelerates Texas Expansion of Licensed Bitcoin ATM Network
-
Telesat schedules first quarter 2026 earnings conference call for May 5, 2026
-
Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
-
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
-
SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.
-
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Serve Robotics to Report First Quarter 2026 Financial Results, Host Conference Call and Webcast on May 7
-
Minoxidil Bay Owned by Fischer Sciences Inc. Expands Access to Minoxidil 5% Hair Regrowth Solutions with Scalable Direct-to-Consumer Platform
-
Northrop Grumman Releases First Quarter 2026 Financial Results
-
Simply Good Foods Announces Cost Savings Initiatives and Leadership Changes as Part of Ongoing Strategic Evolution
-
Man Group PLC : Form 8.3 - Senior plc
-
Man Group PLC : Form 8.3 - JTC Plc
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Mobilicom Secures $2.2 Million in New Purchase Orders for U.S. DoW Program of Record with Tier-1 Drone Manufacturer
-
Talisker Increases Bralorne Gold Project Diamond Drill Program to 105,000 Metres
-
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
-
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
-
Guardforce AI Reports Full Year 2025 Financial Results
-
AAVantgarde announces completion of recruitment in STELLA natural history study
-
Latin Goodness Foods Expands MasPanadas Nationwide Through Partnership with Dot Foods
-
Hangcha Forklift Canada Strengthens Quebec Footprint with Province-Wide Dealer Network
-
Highland Copper Strengthens Leadership With Appointment of Trace Arlaud as Copperwood Project Director and Peter Hemstead as Interim CFO
-
Vicor Corporation Reports Results for the First Quarter Ended March 31, 2026
-
Questor Announces Fourth Quarter and Fiscal Year 2025 Results
-
National Center on Education and the Economy (NCEE) Announces the Global “Rapid Risers” in Education
-
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
-
Amplify ETFs Launches Two Fixed Income Covered Call ETFs for Targeted Annualized Income
-
Aeluma Receives NASA Award for Integrated Quantum Dot Lasers
-
Tecnoglass Sets Date for First Quarter 2026 Results
-
XORTX Meets Nasdaq Continued Listing Requirements
-
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
-
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
-
Mobilicom Secures $2.2 Million in New Purchase Orders for U.S. DoW Program of Record with Tier-1 Drone Manufacturer
-
3D Seismic Survey Materially Expands Lawson Natural Hydrogen Discovery Target Area
-
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
-
PyroGenesis Converts Plasma Gas to Battery-Grade Carbon Black and Hydrogen
-
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
-
The 2026 Payments Canada SUMMIT to convene payment leaders for discussions on strengthening Canada’s economic future
-
The Rise of “Grandma Tourism:” Why almost 70% of travelers prefer learning from older locals when on holiday
-
Nearly 6 in 10 Working Canadians Struggle to Make Ends Meet Each Month Despite Feeling They Earn a Decent Salary – Canadians Divided Around their Financial Outlook in 2026: H&R Block Canada Surv
-
PROFESSOR SIMON CONWAY MORRIS RECEIVES 2026 TEMPLETON PRIZE
-
SurgeXRP To Bring Global Rental Real Estate Onchain Via The XRP Ledger
-
Italiaonline Selects Vendasta’s AI Workforce Platform to Power “MARiO,” Democratizing AI for 100,000+ Italian SMBs
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Bowman to Attend May Investor Conferences
-
Novarra Announces Expansion into Sports Tokenization, Launching Infrastructure to Unlock Global Capital Access for Athletes and Sports Assets
-
Unitil Schedules First Quarter 2026 Earnings Release and Conference Call

